Publikationen von F. Holsboer
Alle Typen
Zeitschriftenartikel (878)
561.
Zeitschriftenartikel
36 (Suppl. 3), S. S207 - S214 (2003)
Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 562.
Zeitschriftenartikel
54 (8), S. 840 - 846 (2003)
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) p-glycoprotein gene disruption. Biological Psychiatry 563.
Zeitschriftenartikel
114 (7), S. 754 - 754 (2002)
The effects of RS-86 on sleep with respect to depression and HLA-type. American Journal of Medical Genetics 564.
Zeitschriftenartikel
114 (7), S. 752 - 753 (2002)
Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome. American Journal of Medical Genetics 565.
Zeitschriftenartikel
114 (7), S. 699 - 699 (2002)
The impact of genomics on antidepressant drug discovery - From serendipity to hypothesis and back. American Journal of Medical Genetics 566.
Zeitschriftenartikel
114 (7), S. 763 - 764 (2002)
Somatic complaints and somatosensory ERPs as vulnerability markers for affective disorders. American Journal of Medical Genetics 567.
Zeitschriftenartikel
114 (7), S. 766 - 767 (2002)
The combined dexamethasone-suppression/corticotropin-releasing-hormone(CRH) stimulation test, a possible endophenotype for major depression? American Journal of Medical Genetics 568.
Zeitschriftenartikel
71 (4 Suppl. Suppl. S), S. 468 - 468 (2002)
Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome. American Journal of Human Genetics 569.
Zeitschriftenartikel
21, S. 4822 - 4829 (2001)
Psychological stress increases hippocampal mineralocorticoid receptor levels: Involvement of corticotropin-releasing hormone. Journal of Neuroscience 570.
Zeitschriftenartikel
108, S. 1197 - 1202 (2001)
Antidepressants do not modulate estrogen receptor α-mediated gene expression. Journal of Neural Transmission 571.
Zeitschriftenartikel
2, S. 165 - 177 (2001)
Antidepressant drug discovery in the postgenomic era. World Journal of Biological Psychiatry 572.
Zeitschriftenartikel
6, S. 590 - 594 (2001)
CRHR1 antagonists as novel treatment strategies. CNS Spectrums 573.
Zeitschriftenartikel
57, S. 47 - 65 (2001)
Prospects for antidepressant drug discovery. Biological Psychology 574.
Zeitschriftenartikel
62, S. 77 - 91 (2001)
Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. Journal of Affective Disorders 575.
Zeitschriftenartikel
25, S. 687 - 691 (2001)
The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Alcoholism: Clinical and Experimental Research 576.
Zeitschriftenartikel
22, S. 835 - 844 (2001)
Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 577.
Zeitschriftenartikel
24, S. 337 - 349 (2001)
Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology 578.
Zeitschriftenartikel
13, S. 373 - 380 (2001)
The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats. European Journal of Neuroscience 579.
Zeitschriftenartikel
62, S. 33 - 37 (2001)
Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the "Munich vulnerability study". Journal of Affective Disorders 580.
Zeitschriftenartikel
158, S. 453 - 468 (2001)
Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. American Journal of Pathology